Emerging markets: a new dawn for the laggards

Investors in emerging-market stocks have had a lousy few years, says Andrew Van Sickle. But things could be looking up.


Does Lula's downfall mark a turning point for Brazil?

Investors in emerging-market stocks have had a lousy few years. But are things now looking up for the global laggards as well? It seems they might well be. Emerging markets "appear to have bottomed", reckon Robert Arnott and Christopher Brightman of Research Affiliates. The MSCI Emerging Market index has jumped by around 15% from its post-crisis low in January.

There have been several false dawns in the past few years, but the fundamentals now seem to be more encouraging than for some time. For one thing, the slump in commodities prices, which "shredded the budgets of producing countries", has abated, say Neil Hume and David Sheppard in the FT.

Oil may now have bottomed as Saudi Arabia has agreed to a production freeze and the US shale industry is "finally showing signs of slowing": US oil output posted its first significant year-on-year decline for almost eight years in December. So investors seem more willing to "look beyond" the glut. China's latest stimulus measures, and the country's evident determination to bolster growth, is also helping. Along with some short covering, this explains the 20% surge in iron-ore prices on Monday.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Emerging markets also suffer if the dollar rises, as the prospect of a higher yield on US assets dents demand for riskier ones. But with the Fed now unlikely to raise rates as fast as everyone expected at the start of the year, and the dollar already historically strong, there is less scope for emerging-market currencies to take another major knock. It's interesting to note, says John Authers in the Financial Times, that an index tracking emerging-market currencies rebounded against the greenback as America suffered its recession scare and has since held on to the gains, even as concern over a US downturn has eased.

Valuations also look appealing after a multi-year bear market. The MSCI index is on a price/earnings ratio of around 11, compared to 16 for the S&P 500; in 2007, at the apex of emerging-market mania, it eclipsed the S&P's valuation. A price-to-book-value ratio of 1.3 also compares favourably to the S&P's 2.4.

Brazil: enter the bull

On that score, it's hard to beat reports that Lula, who in the 2000s "came to personify Brazil's seeming rise to prosperity", as The Daily Telegraph's Ambrose Evans-Pritchard puts it, was detained by police last week. They are investigating an ongoing corruption scandal that has also led to an attempt to impeach his successor, Dilma Rousseff.

Throw in the fact that the economic news can hardly get any worse, and this could be the signal that the emerging-markets tide has turned. Brazil's stocks are already up by 30% from their January low. "When even stocks in bedevilled Brazil enter a bull market," says the Financial Times, "something is definitely going on.

Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.